Bill C-368

An Act to amend the Food and Drugs Act (natural health products)

Sponsor

Blaine Calkins  Conservative

Introduced as a private member’s bill. (These don’t often become law.)

Status

Report stage (House), as of Dec. 2, 2024

Subscribe to a feed (what's a feed?) of speeches and votes in the House related to Bill C-368.

Summary

This is from the published bill. The Library of Parliament often publishes better independent summaries.

This enactment amends the Food and Drugs Act to provide that certain natural health products are not therapeutic products within the meaning of that Act and therefore not subject to the same monitoring regime as other drugs.

Elsewhere

All sorts of information on this bill is available at LEGISinfo, an excellent resource from the Library of Parliament. You can also read the full text of the bill.

Votes

May 29, 2024 Passed 2nd reading of Bill C-368, An Act to amend the Food and Drugs Act (natural health products)

Health Committee, on Oct. 10, 2024

Health Committee, on Oct. 29, 2024

  • Linsey Hollett, Assistant Deputy Minister, Regulatory, Operations and Enforcement Branch, Department of Health
  • Supriya Sharma, Chief Medical Advisor, Department of Health

Health Committee, on Oct. 31, 2024

  • Jasmin Guénette, Vice-President, National Affairs, Canadian Federation of Independent Business
  • Michelle Auger, Senior Policy Analyst, National Affairs, Canadian Federation of Independent Business
  • Jules Gorham, Director, Regulatory Affairs and Policy, Canadian Health Food Association
  • Peter Maddox, President, Direct Sellers Association of Canada
  • Gerry Harrington, Senior Vice-President, Consumer Health, Food, Health & Consumer Products of Canada
  • Aaron Skelton, President and Chief Executive Officer, Canadian Health Food Association
  • Roberta Kramchynsky, Vice-President, Health Policy and Regulatory Affairs, Food, Health & Consumer Products of Canada

Health Committee, on Nov. 7, 2024

  • Joel Thuna, General Manager, Pure-lē Canada, As an Individual
  • Sarah Butson, Chief Executive Officer, Canadian Lung Association
  • Foram Patel, Policy Analyst, Heart and Stroke Foundation of Canada
  • Charlotte Moore Hepburn, Medical Director, Child Health Policy Accelerator, Hospital for Sick Children and Associate Professor, Department of Paediatrics, University of Toronto

Health Committee, on Nov. 19, 2024

  • Flory Doucas, Co-Director and Spokesperson, Coalition québécoise pour le contrôle du tabac
  • Carolyn Hoffman, Chief Executive Officer, Institute for Safe Medication Practices Canada
  • Sylvia Hyland, Vice-President, Operations and Privacy Officer, Institute for Safe Medication Practices Canada
  • Cynthia Callard, Executive Director, Physicians for a Smoke-Free Canada
  • Pierre Chen, Registered Traditional Chinese Medicine Practitioner and Registered Acupuncturist, Traditional Chinese Medicine Association of Canada

Health Committee, on Nov. 21, 2024

Health Committee, on Nov. 28, 2024

  • David Lee, Chief Regulatory Officer, Health Products and Food Branch, Department of Health